Morgan Stanley on Tuesday reduced the price target for hospital operator Almoosa Health Co. (SASE:4018) to 126.50 Saudi riyals from 191.50 riyals and kept its rating at overweight.
What else is happening in Research?
Research
BofA Securities Initiates Coverage on Bel Fuse With Buy Rating, $330 Price Target
Bel Fuse (BELFB) has an average rating of buy and mean price target of $290.17, according to analysts polled by FactSet.Price: $275.07, Change: $+11.81, Percent Change: +4.49%
$BELFB
Research
BofA Securities Initiates Coverage on Columbia Banking System With Buy Rating, $38 Price Target
Columbia Banking System (COLB) has an average rating of overweight and mean price target of $32.69, according to analysts polled by FactSet.Price: $32.43, Change: $+0.44, Percent Change: +1.39%
$COLB
Research
AlphaValue/Baader Europe Downgrades Next to Reduce, Trims PT
AlphaValue/Baader Europe on Tuesday downgraded British retailer Next (NXT.L) to reduce from add and decreased its price target to 155.33 pounds sterling from 156.41 pounds.
$NXT.L